Drugs target to EGLN2

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
ROXADUSTATSmall moleculenoneHypoxia-inducible factor prolyl hydroxylase inhibitor4['Completed', 'Recruiting', 'Completed', 'Completed', 'Completed', '-', 'Completed', 'Active, not recruiting', 'Completed', 'Recruiting', 'Completed', 'Active, not recruiting']['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ATC', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials']
VADADUSTATSmall moleculenoneHypoxia-inducible factor prolyl hydroxylase 1 inhibitor3['Suspended', 'Completed', 'Completed', 'Completed', '-']['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ATC']
DAPRODUSTATSmall moleculenoneHypoxia-inducible factor prolyl hydroxylase inhibitor3['Completed', '-', 'Completed', 'Completed', 'Completed', 'Terminated', 'Terminated', 'Completed']['ClinicalTrials', 'ATC', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials']